Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo tested in fight against Tough-to-Treat blood cancer

NCT ID NCT05259839

Ongoing Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This study is testing the safety and best dose of an experimental drug called etentamig when given with other standard cancer drugs to adults with multiple myeloma that has come back or stopped responding to prior treatments. The main goal is to see how well patients tolerate the combinations and to check for side effects. Researchers will also track if the treatment helps control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Atrium Health Levine Cancer Institute /ID# 242851

    Charlotte, North Carolina, 28204, United States

  • CLINICA UNIVERSIDAD DE NAVARRA-Madrid /ID# 244145

    Madrid, 28027, Spain

  • Calvary Mater Newcastle /ID# 243730

    Waratah, New South Wales, 2298, Australia

  • Clinica Universidad de Navarra - Pamplona /ID# 242977

    Pamplona, Navarre, 31008, Spain

  • Dana-Farber Cancer Institute /ID# 249529

    Boston, Massachusetts, 02215, United States

  • Epworth Healthcare /ID# 243734

    Richmond, Victoria, 3121, Australia

  • Fiona Stanley Hospital /ID# 244753

    Murdoch, Western Australia, 6150, Australia

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 244057

    Milan, 20122, Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 242582

    Rome, Roma, 00168, Italy

  • Froedtert Memorial Lutheran Hospital /ID# 242654

    Milwaukee, Wisconsin, 53226-3522, United States

  • Hokkaido University Hospital /ID# 245966

    Sapporo, Hokkaido, 060-8648, Japan

  • Hospital Clinic de Barcelona /ID# 242978

    Barcelona, 08036, Spain

  • Hospital Duran i Reynals /ID# 242979

    L'Hospitalet de Llobregat, Barcelona, 08907, Spain

  • Hospital Universitario 12 de Octubre /ID# 242975

    Madrid, 28041, Spain

  • Hospital Universitario Vall de Hebron /ID# 242976

    Barcelona, 08035, Spain

  • Hospital Universitario Virgen del Rocio /ID# 242974

    Seville, 41013, Spain

  • Huntsman Cancer Institute /ID# 242872

    Salt Lake City, Utah, 84112-5500, United States

  • IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 242581

    Bologna, 40138, Italy

  • IRCCS Ospedale San Raffaele /ID# 242583

    Milan, Milano, 20132, Italy

  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST - IRCCS /ID# 242584

    Meldola, Reggio Emilia, 47014, Italy

  • Kanazawa University Hospital /ID# 246812

    Kanazawa, Ishikawa-ken, 920-8641, Japan

  • Memorial Sloan Kettering Cancer Center /ID# 244656

    New York, New York, 10065-6007, United States

  • Moffitt Cancer Center /ID# 243437

    Tampa, Florida, 33612-9416, United States

  • Monash Health - Monash Medical Centre /ID# 244403

    Clayton, Victoria, 3168, Australia

  • Nagoya City University Hospital /ID# 249094

    Nagoya, Aichi-ken, 467-8602, Japan

  • National Cancer Center Hospital East /ID# 245889

    Kashiwa-shi, Chiba, 277-8577, Japan

  • Okayama Medical Center /ID# 245882

    Okayama, Okayama-ken, 701-1192, Japan

  • Peter MacCallum Cancer Ctr /ID# 256880

    Melbourne, Victoria, 3000, Australia

  • Rutenberg Cancer Center /ID# 244647

    New York, New York, 10029-6030, United States

  • St George Hospital /ID# 243740

    Kogarah, New South Wales, 2217, Australia

  • St Vincent's Hospital Melbourne /ID# 256879

    Fitzroy Melbourne, Victoria, 3065, Australia

  • Sylvester Comprehensive Cancer Center /ID# 243673

    Miami, Florida, 33136-1002, United States

  • Szpital Wojewodzki w Opolu sp. z o.o. /ID# 243954

    Opole, Lower Silesian Voivodeship, 45-372, Poland

  • The Valley Hospital /ID# 243829

    Paramus, New Jersey, 07652, United States

  • Universitaetsklinikum Essen /ID# 242819

    Essen, 45147, Germany

  • Universitaetsklinikum Hamburg-Eppendorf /ID# 243141

    Hamburg, 20246, Germany

  • Universitaetsklinikum Regensburg /ID# 242837

    Regensburg, 93042, Germany

  • Universitaetsklinikum Tuebingen /ID# 242815

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • Universitaetsklinikum Wuerzburg /ID# 242826

    Würzburg, Bavaria, 97080, Germany

  • University of Arkansas for Medical Sciences /ID# 243096

    Little Rock, Arkansas, 72205, United States

  • University of Maryland, Baltimore /ID# 243679

    Baltimore, Maryland, 21201, United States

  • University of Massachusetts - Worcester /ID# 243977

    Worcester, Massachusetts, 01655, United States

  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 243438

    Ann Arbor, Michigan, 48109, United States

  • University of Texas Southwestern Medical Center /ID# 243273

    Dallas, Texas, 75390-7208, United States

  • University of Washington /ID# 243172

    Seattle, Washington, 98109, United States

  • Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie /ID# 243500

    Lublin, Lublin Voivodeship, 20-081, Poland

  • Uniwersytecki Szpital Kliniczny We Wrocławiu /ID# 243246

    Wroclaw, Lower Silesian Voivodeship, 50-556, Poland

  • Uniwersyteckie Centrum Kliniczne /ID# 243249

    Gdansk, Pomeranian Voivodeship, 80-214, Poland

  • Yamagata University Hospital /ID# 245888

    Yamagata, Yamagata, 990-9585, Japan

Conditions

Explore the condition pages connected to this study.

RELAPSED/REFRACTORY MULTIPLE MYELOMA